Document Type
Article
Publication Date
11-10-2022
Identifier
DOI: 10.1186/s12348-022-00316-z
Abstract
PURPOSE: To report a case of frosted branch angiitis presenting in a pediatric patient with unremarkable laboratory work-up apart from SARS-CoV-2 IgG antibodies.
OBSERVATIONS: Less than four weeks after a SARS-CoV-2 infection, a 10 year-old female presented to the emergency department with severe headache and intermittent fevers. During her hospital admission, the ophthalmology service was consulted for blurry vision. Subsequent eye examination revealed frosted branch angiitis. The patient initially received intravenous corticosteroids but was escalated to plasmapheresis to achieve resolution of her symptoms. Outpatient maintenance therapy consisted of an oral Prednisone taper and Infliximab infusion.
CONCLUSION AND IMPORTANCE: This case represents a unique ocular manifestation of COVID-19, as recent SARS-CoV-2 was the sole identifiable cause of the patient's frosted branch angiitis. Additionally, this patient required plasmapheresis to control disease progression.
Journal Title
J Ophthalmic Inflamm Infect
Volume
12
Issue
1
First Page
38
Last Page
38
Keywords
COVID-19; FROSTED-branch; Vasculitis
Recommended Citation
Alapati A, Cameron N, Gratton S, Stahl E, Champion M. Frosted branch angiitis presenting after a SARS-CoV-2 infection. J Ophthalmic Inflamm Infect. 2022;12(1):38. Published 2022 Nov 10. doi:10.1186/s12348-022-00316-z
Comments
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Link: https://joii-journal.springeropen.com/articles/10.1186/s12348-022-00316-z